Adding Omega-3 Fatty Acids And Lutein/Zeaxanthin To Formulation Does Not Further Reduce Risk Of Progression To Advanced AMD
In a large, multicenter, randomized clinical trial that included persons at high risk for progression to advanced age-related macular degeneration (AMD), adding the carotenoids lutein and zeaxanthin, the omega-3 fatty acids DHA and EPA, or both to a formulation of antioxidant vitamins and minerals that has shown effectiveness in reducing risk did not further reduce risk of prog...